Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

Circulation

Volumn 88, Issue 4, 1993, Pages 1421-1430

  Laakso, Markku ^a,b   Lehto, Seppo ^a   Penttilä, Ilkka ^a   Pyörälä, Kalevi ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cholesterol; Diabetes mellitus; Insulin; Lipids; Lipoproteins

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; CORRELATION FUNCTION; FEMALE; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

CHOLESTEROL; CORONARY DISEASE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMAN; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, VLDL; LIPOPROTEINS, VLDL CHOLESTEROL; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRIGLYCERIDES;

EID: 0027449402     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.88.4.1421     Document Type: Article

References (54)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev. 1987;3:463-524.
2. Santen RJ, Willis PW, Fajans SS. Atherosclerosis in diabetes mellitus: correlations with serum lipid levels, adiposity and serum insulin level. Arch Intern Med. 1972;130:833-843.
3. Goldberg RB. Lipid disorders in diabetes. Diabetes Care. 1981;4: 561-572.
4. Perrett AD, Rowe AS, Shahmanesh M, Allison SP, Hartog M. Blood lipids in treated diabetics. Diabetologia. 1974;10:115-118.
5. Simpson RW, Mann JI, Hockaday JM, Turner RC, Jelfs R. Lipid abnormalities in untreated maturity onset diabetics and the effect of treatment. Diabetologia. 1979;16:101-106.
6. Howard BV, Savage PJ, Bennion LJ, Bennett PH. Lipoprotein composition in diabetes mellitus. Atherosclerosis. 1978;30:153-162.
7. Briones ER, Mao STJ, Palumbo PJ, O'Fallon WM, Chenoweth W, Kottke BA. Analysis of plasma lipids and apolipoproteins in insulin-dependent and non-insulin dependent diabetics. Metabolism. 1984;33:153-162.
8. Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bassett ML, Bierman EL. Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics. Diabetes. 1982;31:126-131.
9. Laakso M, Voutilainen E, Sarlund H, Aro A, Pyörälä K, Penttilä I. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics. Atherosclerosis. 1985;56:271-281.
10. Ganda OP, Soeldner JS, Gleason RE. Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two type II diabetic parents. Diabetes Care. 1985;8:254-260.
11. Laakso M, Barrett-Connor E. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Ateriosclerosis. 1989;9:665-672.
12. Abbott WGH, Lillioja S, Young AA, Zawadzki JK, Yki-Järvinen H, Christie L, Howard B. Relationship between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes. 1987;36:897-904.
13. Garg A, Helderman JH, Koffler M, Ayoso R, Rosenstock J, Raskin P. Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism. 1988;37:982-987.
14. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 1990;10:223-232.
15. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
16. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988;11:449-463.
17. Madsbad S, Alberti KGMM, Binder C, Burrin JM, Faber OK, Krarup T, Regeur L. Role of recidual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetics. BMJ. 1979;2:1257-1259.
18. WHO Expert Committee on Diabetes Mellitus. Second Report: World Health Organization, Technical Report Series 646. Geneva: World Health Organization; 1980.
19. Penttilä IM, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytical and precipitation methods for the direct estimation of serum high density lipoprotein cholesterol. Scand J Chem Lab Invest. 1981;41:353-360.
20. Havel RJ, Eder HA, Bragdon HJ. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
21. Faber OK, Binder C. C-peptide response to glucagon: a test for the residual B-cell function in diabetes mellitus. Diabetes. 1977;26: 605-610.
22. World Health Organization. Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). Geneva: World Health Organization; 1983.
23. National Cholesterol Education Program Expert Panel, National Heart, Lung, and Blood Institute. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med. 1988;148:36-69.
24. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care. 1990;13:153-169.
25. West KM, Ahuja MMS, Bennett PH, Czyczk A, de Acosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Krowlewski AS, Miki E, Schliack V, Teuscher A, Watkins P, Stober JA. The role of circulating glucose and triglyceride concentrations and their interactions with 7ther "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care. 1983;6: 361-369.
26. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warmet JM, Claude JR, Rosselin GE. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective study. Diabetologia. 1989;32:300-304.
27. 2 cholesterol with coronary heart disease in non-insulin-dependent diabetics. Arteriosclerosis. 1985;5:653-658.
28. Ballantyne F, Clark RS, Simpson HS, Ballantyne D. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism. 1982;31:433-437.
29. Hamsten A, Walldius G, Dahlen G, Johansson B, deFaire U. Serum lipoproteins in young male survivors of myocardial infarction. Atherosclerosis. 1986;59:223-235.
30. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation. 1992;85:37-45.
31. Gordon T, Kannel WB, Castelli WB, Dawber TR. Lipoproteins, cardiovascular disease and death: the Framingham Study. Arch Intern Med. 1981;141:1128-1131.
32. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
33. Miller NE. Associations of high density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 1987; 113:589-597.
34. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med. 1989;321:1311-1316.
35. 3 cholesterol, apo A-I and apo A-II, and increased risk of myocardial infarction. Circulation. 1992;85:22-29.
36. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women: the Framingham Study. Ann Intern Med. 1977;87:393-397.
37. Tall AR. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J Clin Invest. 1990;86:379-384.
38. Zilversmith DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-485.
39. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM. Inverse relationship between blood levels of high density lipoprotein subtraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A. 1983;80:1449-1453.
40. Austin MA. Plasma triglyceride as a risk factor for coronary heart disease: the epidemiological evidence and beyond. Am J Epidemiol. 1989;124:249-259.
41. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol. 1992;70:3H-9H.
42. Assmann G, Schulte H. Role of triglycerides in coronary artery disease: lessons from the prospective cardiovascular Munster Study. Am J Cordial. 1992;70:10H-13H.
43. Innerarity TL, Arnold KS, Weisgraber KH, Mahley RW. Apolipoprotein E is the determinant that mediates the receptor uptake of β-very-low density lipoproteins by mouse macrophages. Arteriosclerosis. 1986;6:114-122.
44. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and atherosclerosis: lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med. 1983;309:288-296.
45. James RW, Pometta D. The distribution of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;34: 246-252.
46. Austin MA, Breslow JA, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
47. Howard B. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987;28:613-628.
48. Kissebah AH, Alfrasi S, Evans DJ, Adams PW. Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus. J Clin Invest. 1983;71:655-667.
49. Gordon DJ, Rifkind BM. Treating high blood cholesterol in the older patient. Am J Cardiol. 1989;63:48H-52H.
50. Zilversmith DB. Relative atherogeneticity of different plasma lipoproteins. Adv Exp Med Biol. 1978;109:45-49.
51. Havel RJ. Role of triglyceride-rich lipoproteins in progression of atherosclerosis. Circulation. 1990;81:694-696.
52. Hiramatsu K, Bierman EL, Chait A. Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts. Diabetes. 1985;34:8-14.
53. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 1985;71:881-888.
54. Sarlund H, Pyörälä K, Penttilä I, Laakso M. Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. Arterioscler Thromb. 1992;12: 657-663.